Your search matched 4 results
AN ADVOCACY RX FOR PROGRESS IN MENTAL HEALTH | Perspectives
As a source of human suffering, a barrier to workplace productivity, a burden on families and a driver of medical costs, mental illness amounts to an unparalleled public health crisis.
Mental Health: An Insurance Industry Perspective | Perspectives
In more than 15 hours of interviews, executives at managed care organizations covering more than 59 million lives talked about issues that are top of mind for mental health patients, including medication access and psychiatric care.
Health insurers have raised challenging questions about how drugs for rare diseases are defined, regulated, and priced in the U.S. market.
SHARING THE MISSION TO CONQUER RARE DISEASES | Perspectives
At an ever-quickening pace, biopharmaceutical companies and patient advocacy groups are banding together to hasten development of new drugs for rare diseases.